The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 awarded a $153,924.40 delivery order to CSL Behring L.L.C. under the Pharmaceuticals and Drugs Federal Supply Schedule master contract. The order is for 3,000 units of HAEGARDA C1 Inhibitors (Human) to be delivered to a location in King of Prussia, Pennsylvania by June 3, 2022. The contract has a firm fixed price and no set-aside designation was used. This delivery order will provide a...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 awarded a $105,548.16 delivery order to CSL Behring L.L.C. under the Pharmaceuticals and Drugs Federal Supply Schedule contract. The order is for 3,000 units of Haegarda vials with 48 vials per unit to be delivered by December 14, 2022. The pricing is firm fixed price. The contract was awarded on December 12, 2022 and has no set aside designation. The place of performance is King of...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 awarded a $70,365.44 delivery order to CSL Behring L.L.C. under the Pharmaceuticals and Drugs Federal Supply Schedule contract. The order is for an emergency supply of HAEGARDA to the Richard M. Ross Heart Hospital in King of Prussia, Pennsylvania, with a completion date of February 22, 2022. The contract has a firm fixed price and was awarded on February 15, 2022 without a set-aside...
The Department of Veterans Affairs Veterans Health Administration awarded a $113,280 delivery order against the CSL Behring L.L.C. Pharmaceuticals and Drugs GSA Schedule to provide HAEGARDA injections for Veterans Integrated Service Network 7. CSL Behring will deliver the medication from its facility in King of Prussia, Pennsylvania to locations within VISN 7 over a three-month period concluding September 30, 2023. The firm fixed price order was awarded without any set aside designations to...
CSL Behring L.L.C. was awarded a $70,365.44 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19. The delivery order is for HAEGARDA vials, to be delivered to a location in King of Prussia, Pennsylvania under a firm fixed price contract. No set-aside designation was applied to this award made on January 3rd, 2022 for product delivery by January 6th,...
The Department of Veterans Affairs Veterans Health Administration (VA) awarded a $103,256.12 firm fixed price delivery order to CSL Behring L.L.C. for the supply of HAEGARDA, a C1 inhibitor (human) injection solution, to the VA's Veterans Integrated Service Network 8. This order was placed against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule (FSS) contract with the General Services Administration and the VA. The order has a completion date of December 31, 2018 and did not have...
This is a federal contract award made by the Department of Veterans Affairs (VA) Veterans Health Administration to CSL Behring L.L.C., doing business as CSL Behring LLC, for the delivery of HAEGARDA, a pharmaceutical product used to treat Hereditary Angioedema. The $117,027.68 firm fixed price delivery order was issued against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule contract with the General Services Administration (GSA). The contract has no set-aside designation and...
CSL Behring L.L.C. was awarded an $87,956.80 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22. This delivery order is for the purchase of HAEGARDA, a prescription medication, to fulfill requirements under the VAGLA PHARMACY ORDER OF HAEGARDA. The contract has a completion date of May 31, 2023 and was awarded on June 1, 2022. It utilizes firm fixed...
The Department of Veterans Affairs Veterans Health Administration awarded a delivery order to CSL Behring L.L.C. for the supply of HAEGARDA medication, a treatment for Hereditary Angioedema. The $104,510.10 firm fixed price award was placed against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule contract with the General Services Administration. The contract has no set-aside designation and the place of performance is CSL Behring's facility in King of Prussia, Pennsylvania. CSL...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 awarded a $52,774.08 delivery order to CSL Behring L.L.C. under the Pharmaceuticals and Drugs Federal Supply Schedule contract. The order is for an emergency supply of HAEGARDA to the Richard M. Ross Heart Hospital in King of Prussia, Pennsylvania, with a completion date of July 26, 2022. The contract has a firm fixed price and was awarded non-competitively on July 21, 2022 utilizing the...